Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 201–300 of 860
Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic Disorders
Cho, M.-C., Lee, K., Paik, S.-G., & Yoon, D.-Y. (2008) · PPAR Research · doi:10.1155/2008/679137 · Cited by 89
Planavila, A., Laguna, J. C., & Vázquez‐Carrera, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.004 · Cited by 101
Vrins, C. L. J., van der Velde, A. E., van den Oever, K., Levels, J. H. M., Huet, S., Oude Elferink, R. P. J., Kuipers, F., & Groen, A. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800579-jlr200 · Cited by 89
Molinari, F., Pin, F., Gorini, S., Chiandotto, S., Pontecorvo, L., Penna, F., Rizzuto, E., Pisu, S., Musarò, A., Costelli, P., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12226 · Cited by 97
Calcineurin Regulates Skeletal Muscle Metabolism via Coordinated Changes in Gene Expression
Long, Y. C., Glund, S., Garcia-Roves, P. M., & Zierath, J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609208200 · Cited by 87
PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
Monroy-Ramírez, H. C., Galicia‐Moreno, M., Sandoval-Rodriguez, A. S., Meza-Ríos, A., Santos, A., & Armendáriz‐Borunda, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158298 · Cited by 90
Grimaldi, P. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7278-5 · Cited by 100
Mechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 106
Energy sensing and regulation of gene expression in skeletal muscle
Freyssenet, D. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01126.2005 · Cited by 86
Integrative and Systemic Approaches for Evaluating PPARβ/δ (PPARD) Function
Attianese, G. M. G., & Desvergne, B. (2015) · Nuclear Receptor Signaling · doi:10.1621/nrs.13001 · Cited by 83
Interleukin-15 as a myokine: Mechanistic insight into its effect on skeletal muscle metabolism
Nadeau, L., & Aguer, C. (2019) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2018-0022 · Cited by 83
Mandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 92
Burdick, A. D., Bility, M. T., Girroir, E. E., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.007 · Cited by 92
Inoue, T., Kohro, T., Tanaka, T., Kanki, Y., Li, G., Poh, H.-M., Mimura, I., Kobayashi, M., Taguchi, A., Maejima, T., et al. (2014) · Genome biology · doi:10.1186/gb-2014-15-4-r63 · Cited by 95
Self-citationYamamoto, J., Ikeda, Y., Iguchi, H., Fujino, T., Tanaka, T., Asaba, H., Iwasaki, S., Ioka, R. X., Kaneko, I. W., Magoori, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312079200 · Cited by 90
Self-citationDuszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
Effects of insulin resistance on endothelial progenitor cells and vascular repair
Cubbon, R. M., Kahn, M., & Wheatcroft, S. B. (2009) · Clinical Science · doi:10.1042/cs20080263 · Cited by 90
Jansen, P. L. M. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00001 · Cited by 85
Kamei, Y., Miura, S., Suganami, T., Akaike, F., Kanai, S., Sugita, S., Katsumata, A., Aburatani, H., Unterman, T. G., Ezaki, O., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1461 · Cited by 80
Cheang, W. S., Wong, W. T., Wang, L., Cheng, C. K., Lau, C. W., Ronald, C. W., Xu, A., Wang, N., Huang, Y., & Tian, X. Y. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.041 · Cited by 80
The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 83
The Roles of PPARs in the Fetal Origins of Metabolic Health and Disease
Rees, W. D., McNeil, C. J., & Maloney, C. (2008) · PPAR Research · doi:10.1155/2008/459030 · Cited by 90
de Lange, P., Farina, P., Moreno, M., Ragni, M., Lombardi, A., Silvestri, E., Burrone, L., Lanni, A., Goglia, F., de Lange, P., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6025fje · Cited by 79
Ljubicic, V., Burt, M., & Jasmin, B. (2014) · The FASEB Journal · doi:10.1096/fj.13-238071 · Cited by 76
Iguchi, H., Ikeda, Y., Okamura, M., Tanaka, T., Urashima, Y., Ohguchi, H., Takayasu, S., Kojima, N., Iwasaki, S., Ohashi, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505392200 · Cited by 79
Self-citationEffects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
Choi, Y., Roberts, B. K., Wang, X., Geaney, J. C., Naim, S., Wojnoonski, K., Karpf, D. B., & Krauss, R. M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.029 · Cited by 80
Brunmair, B., Staniek, K., Dörig, J., Szöcs, Z., Stadlbauer, K., Marian, V., Gras, F., Anderwald, C. H., Nohl, H., Waldhäusl, W. K., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0357-6 · Cited by 89
Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates
Rezzi, S., Martin, F.-P. J., Shanmuganayagam, D., Colman, R. J., Nicholson, J. K., & Weindruch, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.02.008 · Cited by 77
Metabolic control of myofibers: promising therapeutic target for obesity and type 2 diabetes
Duan, Y., Li, F., Tan, B., Yao, K., & Yin, Y. (2017) · Obesity Reviews · doi:10.1111/obr.12530 · Cited by 86
Zhou, Y., Murugan, D. D., Khan, H. Z., Huang, Y., & Cheang, W. S. (2021) · Antioxidants · doi:10.3390/antiox10081167 · Cited by 79
Kim, H. J., Ham, S. A., Kim, S. U., Hwang, J.-Y., Kim, J.-H., Chang, K. C., Yabe-Nishimura, C., Kim, J.-H., & Seo, H. G. (2008) · Circulation Research · doi:10.1161/circresaha.107.158477 · Cited by 77
Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors
Mandard, S., Stienstra, R., Escher, P., Tan, N. S., Kim, I., Gonzalez, F. J., Wahli, W., Desvergne, B., Müller, M., & Kersten, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7006-1 · Cited by 77
Morino, K., Petersen, K. F., Sono, S., Choi, C. S., Samuel, V. T., Lin, A., Gallo, A., Zhao, H., Kashiwagi, A., Goldberg, I. J., et al. (2012) · Diabetes · doi:10.2337/db11-1391 · Cited by 77
Nielsen, R., Grøntved, L., Stunnenberg, H. G., & Mandrup, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02266-05 · Cited by 77
Exercise in a Pill: The Latest on Exercise-Mimetics
Guerrieri, D., Moon, H. Y., & van Praag, H. (2016) · Brain Plasticity · doi:10.3233/bpl-160043 · Cited by 85
Ooi, E. M. M., Watts, G. F., Sprecher, D. L., Chan, D. C., & Barrett, P. H. R. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1131 · Cited by 80
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Wu, C.-C., Baiga, T. J., Downes, M., Clair, J. J. L., Atkins, A. R., Richard, S. B., Fan, W., Stockley-Noel, T. A., Bowman, M. E., Noel, J. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621513114 · Cited by 85
Metabolic Networks Influencing Skeletal Muscle Fiber Composition
Bourdeau‐Julien, I., Sephton, C. F., & Dutchak, P. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00125 · Cited by 92
Thamer, C., Machann, J., Stefan, N., Schäfer, S. A., Machicao, F., Staiger, H., Laakso, M., Böttcher, M., Claussen, C., Schick, F., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1209 · Cited by 76
PPAR delta: an uncompletely known nuclear receptor
Fredenrich, A., & Grimaldi, P. A. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70162-3 · Cited by 86
Wang, Y., Chen, X., Huang, Z., Chen, D., Yu, B., Yu, J., Chen, H., He, J., Luo, Y., & Zheng, P. (2020) · Nutrients · doi:10.3390/nu12123811 · Cited by 81
The Zinc Transporter, Slc39a7 (Zip7) Is Implicated in Glycaemic Control in Skeletal Muscle Cells
Myers, S. A., Nield, A., Chew, G.-S., & Myers, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079316 · Cited by 75
Bojic, L. A., Telford, D. E., Fullerton, M. D., Ford, R. J., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Gros, R., Kemp, B. E., Steinberg, G. R., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046037 · Cited by 75
Fujimaki, S., & Kuwabara, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102147 · Cited by 84
Fujii, J., Homma, T., Kobayashi, S., & Seo, H. G. (2018) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v9.i1.1 · Cited by 79
PPARs and LXRs: atherosclerosis goes nuclear
Barish, G. D., & Evans, R. M. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.003 · Cited by 77
The Importance of Fatty Acids as Nutrients during Post-Exercise Recovery
Lundsgaard, A.-M., Fritzen, A. M., & Kiens, B. (2020) · Nutrients · doi:10.3390/nu12020280 · Cited by 72
Metabolic Flexibility and Its Impact on Health Outcomes
Palmer, B. F., & Clegg, D. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.012 · Cited by 93
Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Tan, N. S., Vázquez‐Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.001 · Cited by 84
Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
Choudhary, N. S., Kumar, N., & Duseja, A. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.06.004 · Cited by 73
Foods for the prevention of diabetes: how do they work?
Thomas, T., & Pfeiffer, A. F. H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1229 · Cited by 73
Gaudel, C., Schwartz, C., Giordano, C., Abumrad, N. A., & Grimaldi, P. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00581.2007 · Cited by 72
Girroir, E. E., Hollingshead, H. E., Billin, A. N., Willson, T. M., Robertson, G. P., Sharma, A. K., Amin, S., Gonzalez, F. J., & Peters, J. M. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.023 · Cited by 78
Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy
Tobin, J. F., & Freedman, L. P. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.07.004 · Cited by 78
Olson, E. J., Pearce, G. L., Jones, N. P., & Sprecher, D. L. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.247890 · Cited by 71
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
Han, X., Wu, Y., Yang, Q., & Cao, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107791 · Cited by 75
Takahashi, S., Tanaka, T., Kodama, T., & Sakai, J. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.019 · Cited by 81
Self-citationHollingshead, H. E., Killins, R. L., Borland, M. G., Girroir, E. E., Billin, A. N., Willson, T. M., Sharma, A. K., Amin, S., Gonzalez, F. J., & Peters, J. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm183 · Cited by 71
Liaset, B., Hao, Q., Jørgensen, H., Hallenborg, P., Du, Z.-Y., Ma, T., Marschall, H.-U., Kruhøffer, M., Li, R., Li, Q., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234732 · Cited by 72
Heilbronn, L. K., Gregersen, S., Shirkhedkar, D., Hu, D., & Campbell, L. V. (2007) · Diabetes · doi:10.2337/db06-1687 · Cited by 70
Analysis of the Global RNA Expression Profiles of Skeletal Muscle Cells Treated with Statins
Morikawa, S., Murakami, T., Yamazaki, H., Izumi, A., Saitō, Y., Hamakubo, T., & Kodama, T. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.121 · Cited by 72
Self-citationBernardo, B. L., Wachtmann, T. S., Cosgrove, P. G., Kuhn, M., Opsahl, A. C., Judkins, K. M., Freeman, T. B., Hadcock, J. R., & LeBrasseur, N. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011307 · Cited by 69
Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation
Bugge, A., & Mandrup, S. (2010) · PPAR Research · doi:10.1155/2010/169506 · Cited by 69
Obesity and diabetes: lipids, ‘nowhere to run to'
Hill, M. J., Metcalfe, D., & McTernan, P. G. (2009) · Clinical Science · doi:10.1042/cs20080050 · Cited by 68
Wagner, N., Jehl-Piétri, C., Lopez, P., Murdaca, J., Giordano, C., Schwartz, C., Gounon, P., Hatem, S. N., Grimaldi, P. A., & Wagner, K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp106 · Cited by 80
Yue, T., Nerurkar, S. S., Bao, W., Jucker, B. M., Sarov‐Blat, L., Steplewski, K. M., Ohlstein, E. H., & Willette, R. N. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135327 · Cited by 73
Andrulionytė, L., Peltola, P., Chiasson, J., Laakso, M., & for the STOP-NIDDM Study Group (2006) · Diabetes · doi:10.2337/db05-1629 · Cited by 72
Mehmood, A., Zhao, L., Wang, Y., Pan, F., Hao, S., Zhang, H., Iftikhar, A., & Usman, M. A. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110180 · Cited by 71
Koufany, M., Moulin, D., Bianchi, A., Muresan, M., Sebillaud, S., Netter, P., Weryha, G., & Jouzeau, J.-Y. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2354 · Cited by 66
Constantin, D., Constantin‐Teodosiu, D., Layfield, R., Tsintzas, K., Bennett, A. J., & Greenhaff, P. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.135459 · Cited by 67
PPARδ Activation Protects Endothelial Function in Diabetic Mice
Tian, X. Y., Wong, W. T., Wang, N., Lu, Y., Cheang, W. S., Liu, J., Liu, L., Liu, Y., Lee, S. S. T., Chen, Z., et al. (2012) · Diabetes · doi:10.2337/db12-0117 · Cited by 70
Briand, F., Naik, S. U., Fuki, I. V., Millar, J. S., Macphee, C. H., Walker, M., Billheimer, J. T., Rothblat, G. H., & Rader, D. J. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00098.x · Cited by 76
Kamei, Y., SUZUKI, M. T., Miyazaki, H., Tsuboyama-Kasaoka, N., Wu, J., Ishimi, Y., & Ezaki, O. (2005) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.51.110 · Cited by 74
Araki, M., & Motojima, K. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05183.x · Cited by 65
Sarcolipin overexpression improves muscle energetics and reduces fatigue
Sopariwala, D. H., Pant, M., Shaikh, S. A., Goonasekera, S. A., Molkentin, J. D., Weisleder, N. L., Ma, J., Pan, Z., & Periasamy, M. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01066.2014 · Cited by 73
Lee, M. Y., Choi, R., Kim, H. M., Cho, E. J., Kim, B. H., Choi, Y. S., Naowaboot, J., Lee, E. Y., Yang, Y. C., Shin, J. Y., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.10.066 · Cited by 64
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2014 · Cited by 70
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 63
Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells
Maulucci, G., Daniel, B., Cohen, O., Avrahami, Y., & Sasson, S. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.03.001 · Cited by 64
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J., Vacca, M., & Vidal-Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 63
Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity‐an updated review
Payahoo, L., Khajebishak, Y., & Ostadrahimi, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27913 · Cited by 72
Djouadi, F., Aubey, F., Schlemmer, D., & Bastin, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1936 · Cited by 68
Multiple peroxisome proliferator-activated receptor β subtypes from Atlantic salmon ( Salmo salar )
Leaver, M. J., Ezaz, T., Fontagné-Dicharry, S., Tocher, D. R., Boukouvala, E., & Krey, G. D. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0043 · Cited by 79
Wan, J., Jiang, L., Lü, Q., Ke, L., Li, X., & Tong, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.127 · Cited by 67
A link between hepatic glucose production and peripheral energy metabolism via hepatokines
Abdul-Wahed, A., Gautier-Stein, A., Casteras, S., Soty, M., Roussel, D., Romestaing, C., Guillou, H., Tourette, J.-A., Pleche, N., Zitoun, C., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.005 · Cited by 62
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
Thevis, M., Thomas, A., Kohler, M., Beuck, S., & Schänzer, W. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1584 · Cited by 65
Peters, J. M., Foreman, J. E., & Gonzalez, F. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9320-1 · Cited by 60
Robciuc, M. R., Skrobuk, P., Anisimov, A., Olkkonen, V. M., Alitalo, K., Eckel, R. H., Koistinen, H. A., Jauhiainen, M., & Ehnholm, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046212 · Cited by 61
Yao, P., Morales, J. L., Zhu, B., Kang, B.-H., Gonzalez, F. J., & Peters, J. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0836 · Cited by 66
Thermogenic and metabolic antiobesity drugs: rationale and opportunities
Clapham, J. C., & Arch, J. R. S. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00608.x · Cited by 60
Green tea changes serum and liver metabolomic profiles in mice with high‐fat diet‐induced obesity
Lee, L., Choi, J. H., Sung, M. J., Hur, J., Hur, H. J., Park, J. D., Kim, Y., Gu, E., Min, B., & Kim, H. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400470 · Cited by 62
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells
Rogue, A., Anthérieu, S., Vluggens, A., Umbdenstock, T., Claude, N., de la Moureyre-Spire, C., Weaver, R. J., & Guillouzo, A. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.02.001 · Cited by 65
Insights into the Role of PPARβ/δ in NAFLD
Chen, J., Montagner, A., Tan, N. S., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071893 · Cited by 55
Research Resource: Nuclear Hormone Receptor Expression in the Endocrine Pancreas
Chuang, J.-C., Cha, J.-Y., Garmey, J. C., Mirmira, R. G., & Joyce J., J. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0568 · Cited by 60
Feng, X., Luo, Z., Ma, L., Ma, S., Yang, D., Zhao, Z., Yan, Z., He, H., Cao, T., Liu, D., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01085.x · Cited by 71
Grimaldi, P. A. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.009 · Cited by 73
PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Billin, A. N. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1465 · Cited by 57
Brunelli, L., Cieslik, K. A., Alcorn, J. L., Vatta, M., & Baldini, A. (2007) · Circulation Research · doi:10.1161/01.res.0000260805.99076.22 · Cited by 56
Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs
Yamada, H., Oshiro, E., Kikuchi, S., Hakozaki, M., Takahashi, H., & Kimura, K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047514 · Cited by 61
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.